Medi-Fare Drug
FDA 503B outsourcing facility
Blacksburg, South Carolina
Key Takeaways
- FDA-registered 503B outsourcing facility since 2013
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: June 6, 2025
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- December 17, 2013
- Most recent registration
- December 31, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- June 6, 2025
The FDA last inspected Medi-Fare Drug on June 6, 2025. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.
What this facility compounds
Medi-Fare Drug reports compounding 8 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
- Bupivacaine Hydrochloride; Fentanyl Citrate
- Fentanyl Citrate
- Neostigmine Methylsulfate
- Phenylephrine Hydrochloride
- Povidone-Iodine
- Proparacaine Hydrochloride
- Ropivacaine Hydrochloride
- Succinylcholine Chloride
Location
300 W Pine St, Blacksburg, SC 29702
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Artis Terrell, Jr., 1-318-218-3647. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Medi-Fare Drug with the South Carolina Board of Pharmacy.
503B facilities in South Carolina
South Carolina has 2 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in South Carolina.
Frequently asked questions
Is Medi-Fare Drug registered with the FDA?
Yes. Medi-Fare Drug is a registered 503B outsourcing facility, first registered with the FDA on December 17, 2013 and most recently registered on December 31, 2025.
Has Medi-Fare Drug been inspected by the FDA?
The FDA last inspected Medi-Fare Drug on June 6, 2025. A Form FDA 483 was issued.
Has Medi-Fare Drug had any FDA drug recalls?
No FDA drug recalls are matched to Medi-Fare Drug in the openFDA enforcement database.
What does Medi-Fare Drug compound?
Medi-Fare Drug reports compounding 8 active ingredients to the FDA.
Where is Medi-Fare Drug located?
Medi-Fare Drug is located in Blacksburg, South Carolina (300 W Pine St).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Medi-Fare Drug. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.